The document grounds the piece. On March 3, 2026, Destinus SA was granted US12565304B2, "Heat exchangers for airframes." At high speed, the airframe itself heats up enormously; managing that heat — and often using it, by routing it into the propulsion cycle — is one of the central engineering problems of hypersonic and high-Mach flight. The classification lands in B64C 1/38, the aircraft-structure thermal art.
Now read it the way a capital-markets desk has to. Hypersonic-flight startups are among the most capital-intensive companies in the entire space-and-defense landscape: long development timelines, expensive test campaigns, and no revenue until a vehicle actually flies. The patent estate is the asset that lets such a company keep raising — it is evidence to the next investor that the technical bet is defensible.
And that is the dilution mechanism in one sentence: capability raises money, money costs equity, and equity is finite. Each round that funds the next phase of airframe and propulsion work prices the company higher but hands more of it to new investors. Early backers are betting that the eventual outcome outruns the cumulative dilution. We are not quoting Destinus's cap table — those terms are private and we will not invent them — but the structure is universal to the category.
The wry truth this beat keeps repeating: dilution is the price of survival for a pre-revenue deep-tech company, and a strong patent is what makes the dilution fundable in the first place. A grant on a genuinely hard problem — and airframe thermal management is genuinely hard — is exactly the kind of credibility marker that keeps the financing line open.
So when you see a hypersonic startup tout a patent, read it as both an engineering claim and a fundraising instrument. The grant says the technical fence is real. The cap table, where it eventually becomes public through filings indexed by EdgarBeast, will say what that fence cost the people who built it.